DKT is one of the largest private providers of family planning and reproductive health products and services, providing couples with affordable and safe options for family planning and HIV/AIDS prevention, so they can live empowered lives free from fear of unwanted pregnancy or sexually transmitted diseases.
As the world continues to grapple with the HIV epidemic, DKT launches a major breakthrough in HIV testing amid COVID-19 pandemic.
The first in-home ORAL HIV SELF-TEST KIT – “OraQuick”.
DKT launches the first in-home ORAL HIV SELF-TEST KIT: A major breakthrough in HIV testing
OraQuick detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. It is the first in-home ORAL HIV SELF-TEST to be approved by WHO, NAFDAC, FMOH and US-FDA.
For the first time ever, individuals will have access to an in-home oral test that will empower them to learn their HIV status in the comfort and privacy of their homes. This new in-home rapid test will help individuals at risk for HIV who may not want to test in a clinical setting especially in COVID-19 pandemic times.
OraQuick Oral HIV Self-Test is 99% accurate, very easy to use (just swipe your gum), delivers result in 20 minutes, and it is seen only by you (thus providing confidentiality and preventing HIV-related stigma).
The Oral HIV Self-Test Kit is available in pharmacies and online stores.
0 comments:
Post a Comment